CD14 and COVID-19: Indeed, levels of soluble CD14 (sCD14; monocyte inflammation marker) (Figure 1F) and myeloperoxidase (MPO; neutrophil inflammation marker) (Figure 1G) were significantly higher during severe COVID-19 compared to mild and control groups.